New Analysis Does Not Support Eltrombopag With Immunosuppression in Severe Pediatric Aplastic Anemia
New data are reported from an ongoing, prospective, nonrandomized phase 1/2 study of eltrombopag added to immunosuppressive therapy for patients with treatment-naive severe aplastic anemia.